Cure Leukaemia help connect blood cancer patients, that have exhausted standard treatments for the disease, with pioneering and potentially life-saving drugs through clinical trials. The charity fund specialist research nurses in the Midlands and across the UK to run these lifesaving trials. Only by funding more nurses in hospitals, can more blood cancer patients benefit from access to potentially life-saving treatment.
Cure Leukaemia CEO James McLaughlin said: “We are immensely grateful for the support Gala Events have given the charity in recent years. In 2017, thanks to their support, we were able to raise an additional £1m to help fund the £3.4m expansion of the world renowned Centre for Clinical Haematology at the Queen Elizabeth Hospital in Birmingham. The Centre, which reopened in January 2018, now has double its capacity for blood cancer patients treated, clinical trials opened and research nurses employed. We look forward to continuing our partnership with Gala Events to give patients hope and hasten global progress towards eradicating all forms of blood cancer within 25 years.”